Preeclampsia is a hypertensive disorder of pregnancy with maternal organ dysfunction, usually after 20 weeks' gestation, and can progress to severe maternal and fetal complications.
Amneal Pharmaceuticals recalls magnesium sulfate after a pouch intended for pregnant women was found containing tranexamic acid instead. The medication mix-up could cause serious adverse events including seizures and blood clotting if administered incorrectly.
New research from 18 countries shows COVID-19 vaccination during pregnancy, particularly with booster doses, significantly reduces the risk of preeclampsia and other serious complications for both mothers and babies.
The Preeclampsia Foundation released a new educational resource to help OB-GYNs navigate predictive and diagnostic biomarker testing for hypertensive disorders of pregnancy, covering FDA-cleared tests from Thermo Fisher Scientific and Roche Diagnostics.
A trial at Tygerberg Hospital in Cape Town tested DM199, a drug originally developed for stroke, in pregnant women with severe preeclampsia. The drug stabilized dangerously high blood pressure after researchers found the effective dose in the 16th patient.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07599579 |
Mobile Health Program for Post-Preeclampsia Hypertension |
NOT_YET_RECRUITING | NA |
| NCT07572656 |
Comparison of Intravenous Labetalol and Intravenous Hydralazine in Severe Preeclampsia |
COMPLETED | NA |
| NCT07565727 |
Cardiometabolic Disease and Substrate Metabolism |
RECRUITING | |
| NCT07564856 |
Climate-Safe Pregnancy Intervention for Women With Preeclclampsia |
COMPLETED | NA |
| NCT07559773 |
The ROOT Study: Scaling the 'Standard of Care Plus' Obstetric Nutrition Model to Optimize Maternal and Infant Health |
NOT_YET_RECRUITING | NA |
| NCT07514130 |
Assessment of Volume Status in Preeclampsia Post- SpinalAnasthesia:Utilizing Ultrasound " Evaluation of Lung and Inferior Vena Cava" |
ACTIVE_NOT_RECRUITING | EARLY_PHASE1 |
| NCT07510568 |
Vitamin D Supplementation Among Pregnant Women in Uganda for the Prevention of Hypertensive Disorders in Pregnancy, and Other Adverse Maternal and Foetal Outcomes |
NOT_YET_RECRUITING | PHASE4 |
| NCT07496788 |
Investigation of the Role of Internal Jugular Vein Collapsibility Index in Predicting Spinal Anesthesia-Induced Hypotension in Preeclamptic Parturients |
NOT_YET_RECRUITING | |
| NCT07479329 |
Estimated Risk of Preeclampsia in the First Trimester and Its Association With Subclinical Atherosclerosis and Cardiovascular Risk in Women With Type 1 Diabetes |
NOT_YET_RECRUITING | |
| NCT07467226 |
MATERNAL SERUM CADHERİN-6 AS A PREDİCTOR OF PREECLAMPSİA |
COMPLETED |
